Inder Puri
Overview
Explore the profile of Inder Puri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar A, Singh A, Anand P, Pandey D, Gupta S, K L, et al.
Indian J Pediatr
. 2025 Feb;
PMID: 39899196
Objectives: To assesses the coverage, adherence, reasons for non-initiation and non-completion of tuberculosis preventive treatment (TPT) among household child contacts (HHCC) of pulmonary tuberculosis (TB). Methods: This cross-sectional study was...
2.
Pandian J, Phillips A, Verma S, Arora D, Dhasan A, Raju P, et al.
Int J Stroke
. 2024 Dec;
:17474930241307933.
PMID: 39633570
Rationale: Early mortality in intracerebral hemorrhage (ICH) is due to hematoma volume (HV) expansion, and there are no effective treatments available other than reduction in blood pressure. Tranexamic acid (TXA)...
3.
Salunkhe M, Haldar P, Bhatia R, Prasad D, Gupta S, Srivastava M, et al.
Int J Stroke
. 2023 Aug;
19(1):76-83.
PMID: 37577976
Background: India accounts for 13.3% of global disability-adjusted life years (DALYs) lost due to stroke with a relatively younger age of onset compared to the Western population. In India's public...
4.
Sireesha Y, Shree R, Nagappa M, Patil A, Singla M, Srivastava M, et al.
Ann Indian Acad Neurol
. 2023 Mar;
25(6):1116-1121.
PMID: 36911481
Introduction/aims: Studies conducted during the coronavirus disease 2019 (COVID-19) pandemic have reported varied data regarding the incidence of Guillain-Barre syndrome (GBS). The present study investigated demographic and clinical features, management,...
5.
Bhatia R, Haldar P, Puri I, Srivastava M, Bhoi S, Jha M, et al.
Ann Indian Acad Neurol
. 2022 Oct;
25(4):640-646.
PMID: 36211192
Introduction: In India, a national program for stroke (national programme for the control of cardiovascular diseases, diabetes, cancer, and stroke) and stroke management guidelines exist. Its successful implementation would need...
6.
Ola V, Puri I, Goswami D, Vibha D, Shukla G, Goyal V, et al.
Ann Indian Acad Neurol
. 2022 Oct;
25(4):660-663.
PMID: 36211186
Background: Parkinson's disease (PD) is a slowly progressive and disabling disorder, so the cost of illness may change with time. We aimed this study to know the annual cost of...
7.
Garg D, Dhamija R, Choudhary A, Shree R, Kumar S, Samal P, et al.
Ann Indian Acad Neurol
. 2022 Mar;
25(1):60-67.
PMID: 35342256
Objective: To study impact of COVID-19 pandemic on frequency, clinical/electrophysiological profile and treatment outcomes in pediatric Guillain-Barré syndrome (GBS). Background: GBS is the most frequent cause of pediatric acute flaccid...
8.
Nehara H, Puri I, Singhal V, Ih S, Bishnoi B, Sirohi P
Indian J Med Microbiol
. 2021 May;
39(3):380-383.
PMID: 34052046
Coronavirus disease 2019 (COVID-19), may present with a myriad of clinical manifestations and complications. Patients with COVID-19 are at increased risk of pulmonary thromboembolism, acute cardiac injury, arrhythmias, acute stroke,...
9.
Budania A, Mandal S, Pathania Y, Lahoria U, Khan M, Puri I, et al.
J Cosmet Dermatol
. 2021 Apr;
20(10):3245-3252.
PMID: 33793043
Background: Platelet-rich plasma (PRP) has been found to be effective in treating periorbital hyperpigmentation (POH). PRP prepared by double-spin (DS) method and activated by calcium has been used conventionally. PRP...
10.
Goswami D, Singh K, Bhardwaj P, Panda S, Goel A, Joshi N, et al.
Ann Indian Acad Neurol
. 2021 Feb;
23(5):661-665.
PMID: 33623268
Objective: A cost of illness study was conducted with aims to asses various cost of acute stroke care and its determinants among beneficiary (patients enrolled in any social security scheme)...